MDR-101

DB18513InvestigationalCell transplant therapies

MDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells.

Code names
MDR-101

Resolves to

Compound
UNIIP4NC6C4ABZ

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of MDR-101, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In